Literature DB >> 24992086

Antipsychotics-induced tardive syndrome: a retrospective epidemiological study.

Min-Jing Lee1, Pao-Yen Lin, Yung-Yee Chang, Mian-Yoon Chong, Yu Lee.   

Abstract

OBJECTIVES: Only little information of the epidemiology of tardive syndrome in patients using antipsychotics is available. Herein, we aimed to investigate the prevalence and risk factors of antipsychotics-induced tardive syndrome.
METHODS: This study was conducted by means of a retrospective survey. Subjects receiving antipsychotics for more than 6 months, but no other agents that may cause involuntary movements, were consecutively recruited. Tardive syndrome was evaluated in every included subject. Possible confounding medical conditions were carefully ruled out.
RESULTS: Of the 123 included subjects, 35 (28.5%) were found to have at least 1 episode of tardive syndrome. The prevalence of subtypes of tardive syndrome were as follows: tardive dyskinesia, 21.1%; tardive dystonia, 12.5%; tardive tremor, 2.4%; and tardive akathisia, 2.4%. Concurrent physical illness and a history of extrapyramidal symptoms were significant risk factors for tardive syndrome.
CONCLUSIONS: This study showed that antipsychotics may induce various types of tardive syndrome, of which tardive dyskinesia is the most predominant one. Physicians should be aware of this common and distressing adverse effect when using antipsychotics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24992086     DOI: 10.1097/WNF.0000000000000040

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  5 in total

1.  Acceptance-based Behavior Therapy for Depression With Psychosis: Results From a Pilot Feasibility Randomized Controlled Trial.

Authors:  Brandon A Gaudiano; Andrew M Busch; Susan J Wenze; Kathryn Nowlan; Gary Epstein-Lubow; Ivan W Miller
Journal:  J Psychiatr Pract       Date:  2015-09       Impact factor: 1.325

2.  Resveratrol Protects Against Vacuous Chewing Movements Induced by Chronic Treatment with Fluphenazine.

Authors:  Alcindo Busanello; Caroline Queiroz Leal; Luis Ricardo Peroza; Jivago Röpke; Elizete de Moraes Reis; Catiuscia Molz de Freitas; Milena Libardoni; Nilda Berenice de Vargas Barbosa; Roselei Fachinetto
Journal:  Neurochem Res       Date:  2017-07-25       Impact factor: 3.996

Review 3.  Medical and Surgical Treatment for Medication-Induced Tremor: Case Report and Systematic Review.

Authors:  Wardell E Amerika; Saskia van der Gaag; Arne Mosch; Niels A van der Gaag; Carel F E Hoffmann; Rodi Zutt; Johan Marinus; Maria Fiorella Contarino
Journal:  Mov Disord Clin Pract       Date:  2022-05-24

4.  Drug-Induced Movement Disorders and Its Associated Factors Among Patients Attending Treatment at Public Hospitals in Eastern Ethiopia.

Authors:  Tadesse Misgana; Niguse Yigzaw; Getachew Asfaw
Journal:  Neuropsychiatr Dis Treat       Date:  2020-08-17       Impact factor: 2.570

Review 5.  Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges.

Authors:  Haitham Salem; Caesa Nagpal; Teresa Pigott; Antonio Lucio Teixeira
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.